Salipro Biotech Expands Global Intellectual Property Portfolio with Granted Patents in Australia and Singapore

Salipro Biotech strengthens its global intellectual property portfolio with granted patents in Singapore and Australia, protecting its proprietary Salipro® platform technology to enable the development of therapeutics against challenging drug targets. STOCKHOLM, Dec. 5, 2024 /PRNewswire/…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.